Companies/US/EIKN

EIKON THERAPEUTICS, INC.

Last · —$7.01+0.29 (+4.32%)live · yahoo · 0s ago
Vol 595.5K ≈ 4.17M
Market cap$379.70M54.2M sh
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield0.00%annual · TTM
52w range
$6.72$16.26
Volume595.5Ksession

Issuer

Legal nameEIKON THERAPEUTICS, INC.
HQUnited States (US)
ListingUS EIKN
ISINUS2825641036
SectorHealthcare
IndustryBiotechnology & Medical Research
SIC2836
CurrencyUSD
Entity registrysec:0001861123
CIK0001861123
Websitewww.eikontx.com
Employees384
AddressEikon Therapeutics, Inc. 230 Harriet Tubman Way 94030, Millbrae
Loading chart…

Upcoming earnings

1 event
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$1.58
Est. revenue
0
View upcoming earnings →

Press & signals

3 recent
  • GlobeNewswire

    Eikon Therapeutics Appoints Ching-Pin Chang, M.D., Ph.D. as Executive Vice President and Chief Scientific Officer

  • GlobeNewswire

    Eikon Therapeutics Reports Second Quarter 2026 Financial Results and Provides Clinical Updates

  • GlobeNewswire

    Eikon Therapeutics Appoints Johnny Bennett, Ph.D. to its Scientific Advisory Board

Documents

FormReporting forFiledFlags
4
2026-09-032026-09-080
8-K8-K: Regulation FD Disclosure
2026-08-132026-08-140
8-K8-K: Results of Operations and Financial Condition
2026-08-132026-08-130
10-Q
2026-06-302026-08-13 3
8-K8-K: Departure of Directors or Certain Officers; Election of Directors
2026-07-312026-08-030
Showing 5 of 24 filings